Gary Gustafson

Senior Customer Success Specialist, CAS

Bio

Emerging Science

Are covalent inhibitors the key to curing cancer?

CAS and Totus Medicines discuss how targeted covalent inhibitors are revolutionizing cancer treatments.
|Article